Rodgers & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Buy
2,456
+1,108
+82% +$258K 0.06% 68
2026
Q1
$330K Hold
1,348
0.03% 81
2025
Q4
$279K Buy
1,348
+239
+22% +$47.3K 0.03% 87
2025
Q3
$206K Buy
+1,109
New +$190K 0.02% 102
2022
Q3
Sell
-1,758
Closed -$312K 83
2022
Q2
$312K Buy
1,758
+51
+3% +$9.09K 0.05% 68
2022
Q1
$303K Sell
1,707
-111
-6% -$18.9K 0.05% 75
2021
Q4
$311K Buy
1,818
+285
+19% +$46.7K 0.05% 76
2021
Q3
$248K Hold
1,533
0.04% 84
2021
Q2
$253K Buy
1,533
+50
+3% +$8.28K 0.04% 81
2021
Q1
$244K Sell
1,483
-305
-17% -$49.4K 0.04% 81
2020
Q4
$281K Buy
+1,788
New +$264K 0.05% 75

Other funds holding JNJ

Rodgers & Associates's JNJ Position: Q2 2026 in Review

Rodgers & Associates increased its Johnson & Johnson (JNJ) stake by 82% in Q2 2026, buying an estimated $258K and bringing the position to 2,456 shares worth $624K. The position accounts for 0.06% of the portfolio, ranked #68.

Rodgers & Associates first reported a position in JNJ in Q4 2020 and has held it in 11 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rodgers & Associates held 2,456 shares of Johnson & Johnson worth $624K as of Q2 2026.
  • Rodgers & Associates bought 1,108 Johnson & Johnson shares in Q2 2026, an estimated $258K.
  • Johnson & Johnson made up 0.06% of Rodgers & Associates's portfolio in Q2 2026, its #68 holding.
  • Rodgers & Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 11 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rodgers & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.